May 1, 2026, 4:47 AMproactiveinvestors.co.ukRTC
PureTech Health shares boosted as investee Seaport Therapeutics prices Nasdaq IPO
Prospectus, capital raise, listingCapital and holders
PureTech Health (LSE:PRTC, NASDAQ:PRTC, OTC:PTCHF, FRA:0VQ) told investors that its founded entity Seaport Therapeutics has priced an upsized US initial public offering at the top of its target range, putting the clinical-stage neuropsychiatry company on course to raise gross proceeds of $254.9 million. In London, PureTech shareholders saw the share price climb 9.56% to 139.8p.